The impact of early therapies for COVID-19 on death, hospitalization and persisting symptoms: a retrospective study

PURPOSE: Oral antivirals (nirmatrelvir/ritonavir and molnupiravir), intravenous short treatment of remdesivir and anti-SARS-CoV-2 monoclonal antibodies (mAbs) have been used for early COVID-19 treatments in high risk of disease progression patients. The term long COVID has been used to refer to a ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertuccio, Paola, Degli Antoni, Melania, Minisci, Davide, Amadasi, Silvia, Castelli, Francesco, Odone, Anna, Quiros-Roldan, Eugenia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079146/
https://www.ncbi.nlm.nih.gov/pubmed/37024626
http://dx.doi.org/10.1007/s15010-023-02028-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079146/
https://www.ncbi.nlm.nih.gov/pubmed/37024626
http://dx.doi.org/10.1007/s15010-023-02028-5

Ejemplares similares